PCOS Blood Tests: Hormones Needed and the Role of LH/FSH Ratio

What Is Polycystic Ovary Syndrome (PCOS)?

Polycystic Ovary Syndrome (PCOS) is one of the most prevalent endocrine and metabolic disorders affecting women of reproductive age. It is not limited to the ovaries but represents a complex hormonal imbalance involving elevated androgen levels, impaired follicular development, and systemic metabolic effects.

Clinical presentation varies significantly among individuals. Some women experience severe menstrual irregularity or oligomenorrhea, while others present primarily with dermatological signs of hyperandrogenism, such as hirsutism or persistent acne, or face reproductive challenges, including delayed pregnancy. Importantly, PCOS is a manageable condition with appropriate clinical oversight and personalized care strategies.

Does Polycystic Appearance on Ultrasound Confirm PCOS?

A common misconception is equating polycystic ovarian morphology detected on pelvic ultrasound with a definitive diagnosis of PCOS. According to the internationally established Rotterdam criteria, a diagnosis requires meeting at least two of the following three parameters:

• Oligo- or anovulation (irregular or absent menstrual cycles).
• Clinical and/or biochemical signs of hyperandrogenism.
• Polycystic ovarian morphology on ultrasound (a specific follicle count or volume threshold).

Therefore, polycystic appearance alone on an ultrasound scan without additional criteria does not establish a diagnosis of PCOS, as multifollicular ovaries can occur normally in young women without hormonal pathology.

What Is the Role of LH and FSH?

Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) are gonadotropins secreted by the anterior pituitary gland to regulate ovarian function and the menstrual cycle:

• FSH: Stimulates follicular recruitment and egg maturation in the early phase of the cycle.
• LH: Triggers the mid-cycle surge required for ovulation and luteinization.

In PCOS, altered neuroendocrine pulse frequency often leads to an inappropriate elevation of LH relative to FSH during the early follicular phase, disrupting normal follicular maturation.

Does the LH to FSH Ratio Diagnose PCOS?

While an altered LH to FSH ratio (often 2:1 or 3:1) was historically highlighted in clinical observations, modern clinical guidelines do not consider this ratio a standalone diagnostic criterion for PCOS.

Many women with confirmed PCOS display a normal LH to FSH ratio, and elevated ratios can occur in other conditions. Physicians rely on a comprehensive clinical evaluation combining patient history, physical examination, androgen biomarkers, and ultrasound imaging rather than a single hormone ratio.

What Are Androgen Blood Tests?

Evaluating hyperandrogenism is central to the biochemical assessment of suspected PCOS. A comprehensive evaluation may include a testosterone panel and related assays:

• Total and Free Testosterone: Free testosterone measurement is generally the most sensitive lab marker for detecting hyperandrogenemia.
• Sex Hormone-Binding Globulin (SHBG): Often reduced in women with PCOS, leading to higher biologically active free testosterone levels.
• Dehydroepiandrosterone Sulfate (DHEA-S): An adrenal androgen marker that helps rule out adrenal source hyperandrogenism.
• Androstenedione: Serves as an additional marker of ovarian and adrenal androgen secretion.

Is AMH Used for PCOS Diagnosis?

Anti-Müllerian hormone (AMH) is produced by small preantral and antral follicles in the ovaries. Because women with PCOS typically have an increased number of small antral follicles, serum AMH levels are frequently elevated.

An AMH blood test offers valuable clinical insight into follicular reserve and ovarian activity. While recent international evidence-based guidelines recognize AMH as a supportive marker for ovarian morphology, it is not used as a sole diagnostic test.

Why Do Doctors Order TSH and Prolactin?

When evaluating suspected PCOS, excluding other endocrine disorders that present with similar menstrual irregularities and androgen excess symptoms is essential. Key differential diagnostic tests include:

• Thyroid-Stimulating Hormone (TSH): Excludes hypothyroidism or hyperthyroidism affecting ovulation.
• Prolactin: Rules out hyperprolactinemia as a cause of ovulatory dysfunction.
• 17-Hydroxyprogesterone (17-OHP): Excludes non-classic congenital adrenal hyperplasia (NCCAH).

What Metabolic Tests May Be Discussed?

PCOS is closely associated with metabolic alterations, particularly insulin resistance test evaluations. Comprehensive patient management often involves metabolic screening:

How Does PCOS Impact Ovulation and Fertility?

Hormonal imbalance in PCOS halts follicular maturation, preventing a dominant follicle from releasing a mature egg, resulting in anovulatory cycles. This mechanism explains why some women experience subfertility or delayed conception.

However, PCOS does not equate to permanent infertility. With structured lifestyle interventions and medical ovulation induction therapies supervised by a specialist, many women successfully achieve healthy pregnancies.

Can Lab Results Be Normal in PCOS?

Yes. Biochemical blood tests can fall within normal reference ranges in individuals who clinically meet diagnostic criteria for PCOS. Reasons include

• Fluctuations based on cycle phase timing during blood sampling.
• Diagnosis based on clinical hyperandrogenism (such as hirsutism) combined with irregular cycles, even if circulating hormone levels measure normal.
• Heterogeneity in clinical presentation across different phenotype classifications.

When to Consult a Gynecologist or Endocrinologist?

Medical consultation with a specialist is recommended under the following clinical circumstances:

• Menstrual absence or delay lasting more than three consecutive months.
• Rapid onset or severe progress of hirsutism or treatment-resistant acne.
• Difficulty conceiving after 12 months of regular unprotected intercourse (or 6 months if aged 35 or older).
• Signs of metabolic dysfunction such as unexplained weight gain or dark skin patches (acanthosis nigricans).

A comprehensive professional assessment remains the essential foundation for accurate diagnosis and personalized clinical management.